Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aragen Life Sciences is a leading global contract research, development, and manufacturing organization (CRO/CDMO) providing integrated discovery, development, and manufacturing solutions for the life sciences industry. Formerly known as GVK BIO, the company rebranded in 2021 to reflect its expanded capabilities and global footprint, which includes major facilities in India and the United States. Aragen offers a comprehensive suite of services across small molecules and biologics, including medicinal chemistry, biology, ADME/PK, process R&D, and clinical-stage manufacturing. Their biologics division, Aragen Bioscience, specializes in cell line development using their proprietary RapTr platform, protein expression, and purification, supporting clients from early-stage research through to commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ARAG.